Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Journal of Endotoxin Research|November 24, 2005
Peptidoglycan recognition by the Drosophila Imd pathwayTakashi Kaneko, Douglas Golenbock, Neal SilvermanNature Reviews. Immunology|May 18, 2013
The history of Toll-like receptors - redefining innate immunityLuke A J O'Neill, Douglas Golenbock, Andrew G BowieJournal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
The role of lipopolysaccharide binding protein in resistance to Salmonella infections in miceJoshua Fierer, Mark A Swancutt, Didier Heumann, et al.Infection and Immunity|April 27, 2011
Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensisCarolina Gallego, Douglas Golenbock, Maria Adelaida Gomez, et al.Alzheimer'S Research & Therapy|June 6, 2020
Immediate and long-term consequences of COVID-19 infections for the development of neurological diseaseMichael T Heneka, Douglas Golenbock, Eicke Latz, et al.Cellular and Molecular Life Sciences : CMLS|August 29, 2012
NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1β and neuronal toxicityIva Hafner-Bratkovič, Mojca Benčina, Katherine A Fitzgerald, et al.Infection and Immunity|November 22, 2005
Comparative toll-like receptor 4-mediated innate host defense to Bordetella infectionPaul B Mann, Daniel Wolfe, Eicke Latz, et al.Nature Medicine|June 19, 2007
Identification of a key pathway required for the sterile inflammatory response triggered by dying cellsChun-Jen Chen, Hajime Kono, Douglas Golenbock, et al.Journal of Leukocyte Biology|October 6, 2005
Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnesLaszlo Romics, Angela Dolganiuc, Arumugam Velayudham, et al.Plos One|January 5, 2013
Dried whole plant Artemisia annua as an antimalarial therapyMostafa A Elfawal, Melissa J Towler, Nicholas G Reich, et al.Pageof 5